Compounds > azacrin
Page last updated: 2024-09-05

azacrin and puromycin

azacrin has been researched along with puromycin in 1 studies

Compound Research Comparison

Studies
(azacrin)		Trials
(azacrin)		Recent Studies (post-2010)
(azacrin)		Studies
(puromycin)		Trials
(puromycin)		Recent Studies (post-2010) (puromycin)
6005,8281311

Protein Interaction Comparison

ProteinTaxonomyazacrin (IC50)puromycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.9
30S ribosomal protein S7Escherichia coli K-120.9
50S ribosomal protein L15Escherichia coli K-120.9
50S ribosomal protein L10Escherichia coli K-120.9
50S ribosomal protein L11Escherichia coli K-120.9
50S ribosomal protein L7/L12Escherichia coli K-120.9
50S ribosomal protein L19Escherichia coli K-120.9
50S ribosomal protein L1Escherichia coli K-120.9
50S ribosomal protein L20Escherichia coli K-120.9
50S ribosomal protein L27Escherichia coli K-120.9
50S ribosomal protein L28Escherichia coli K-120.9
50S ribosomal protein L29Escherichia coli K-120.9
50S ribosomal protein L31Escherichia coli K-120.9
50S ribosomal protein L31 type BEscherichia coli K-120.9
50S ribosomal protein L32Escherichia coli K-120.9
50S ribosomal protein L33Escherichia coli K-120.9
50S ribosomal protein L34Escherichia coli K-120.9
50S ribosomal protein L35Escherichia coli K-120.9
50S ribosomal protein L36Escherichia coli K-120.9
30S ribosomal protein S10Escherichia coli K-120.9
30S ribosomal protein S11Escherichia coli K-120.9
30S ribosomal protein S12Escherichia coli K-120.9
30S ribosomal protein S13Escherichia coli K-120.9
30S ribosomal protein S16Escherichia coli K-120.9
30S ribosomal protein S18Escherichia coli K-120.9
30S ribosomal protein S19Escherichia coli K-120.9
30S ribosomal protein S20Escherichia coli K-120.9
30S ribosomal protein S2Escherichia coli K-120.9
30S ribosomal protein S3Escherichia coli K-120.9
30S ribosomal protein S4Escherichia coli K-120.9
30S ribosomal protein S5Escherichia coli K-120.9
30S ribosomal protein S8Escherichia coli K-120.9
30S ribosomal protein S9Escherichia coli K-120.9
50S ribosomal protein L13Escherichia coli K-120.9
50S ribosomal protein L14Escherichia coli K-120.9
50S ribosomal protein L16Escherichia coli K-120.9
50S ribosomal protein L23Escherichia coli K-120.9
30S ribosomal protein S15Escherichia coli K-120.9
50S ribosomal protein L17Escherichia coli K-120.9
50S ribosomal protein L21Escherichia coli K-120.9
50S ribosomal protein L30Escherichia coli K-120.9
50S ribosomal protein L6Escherichia coli K-120.9
30S ribosomal protein S14Escherichia coli K-120.9
30S ribosomal protein S17Escherichia coli K-120.9
30S ribosomal protein S1Escherichia coli K-120.9
50S ribosomal protein L18Escherichia coli K-120.9
Puromycin-sensitive aminopeptidaseHomo sapiens (human)6.075
50S ribosomal protein L2Escherichia coli K-120.9
50S ribosomal protein L3Escherichia coli K-120.9
50S ribosomal protein L24Escherichia coli K-120.9
50S ribosomal protein L4Escherichia coli K-120.9
50S ribosomal protein L22Escherichia coli K-120.9
50S ribosomal protein L5Escherichia coli K-120.9
30S ribosomal protein S21Escherichia coli K-120.9
50S ribosomal protein L25Escherichia coli K-120.9
50S ribosomal protein L36 2Escherichia coli K-120.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y1

Other Studies

1 other study(ies) available for azacrin and puromycin

ArticleYear
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-01, Volume: 105, Issue:26

    Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2008